You Position: Home > Paper

Evaluation on the cardiovascular safety ot AIDS patients with highly active antiretroviral therapy by echocardiography

( views:332, downloads:68 )
Author:
No author available
Journal Title:
Chinese Journal of Primary Medicine and Pharmacy
Issue:
12
DOI:
10.3760/cma.j.issn.1008-6706.2012.12.001
Key Word:
抗逆转录病毒治疗;高效;超声心动描记术;心脏功能试验;Antiretroviral therapy;highly active;Echocardiography;Heart function tests

Abstract: Objective To explore the clinical value of echocardiography in evaluating the cardiovascular safety of drugs for AIDS patients treated by highly active antiretroviral therapy(HAART).Methods 45 HIV-infected patients accepted three times of echocardiography respectively before the treatment,and after 48 weeks of HAART and 96 weeks of HAART.All kinds of echocardiographic parameters were measured.Results There were statistically significant differences among baseline group pretreatment [V-LVOT:( 115.0 ± 13.8 ) cm/s,EDT:(166.8 ± 26.7) cm/s,E':(26.8±6.7)cm/s],48 weeks [V-LVOT:( 113.0 ± 12.9)cm/s,EDT:(172.9±31.0)cm/s,E':(23.8 ±5.0)cm/s] of HAART and96 weeks[V-LVOT:(107.0±13.3)cm/s,EDT:(140.4 ± 19.3)cm/s,E':(22.7±6.4)cm/s]of HAART for parameters of V-LVOT,EDT and E'( all P < 0.05 ),other echocardiographic parameters showed no statistically significant differences(all P>0.05).Conclusion Short-term of HAART was provided with cardiovascular safety,the invasive echocardiography could accurately evaluate the cardiac function and structure of AIDS patients with HAART.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn